POS1417 DO SOCIAL FACTORS IMPACT ON BIOLOGICS COSTS IN RHEUMATOID ARTHRITIS? RESULTS FROM THE MOROCCAN RBSMR REGISTRY

Background: Objectives: The aim of this study was to estimate the annual direct cost biologics in rheumatoid arthritis and evaluate impact social factors on biological use costs. Methods: Patients Moroccan register biologicals (RBSMR) with available 1-year data were included. Variables related socio-economic status, disease collected. Direct costs included prices biologics, infusions, subcutaneous injections. Biological compared based factors. Results: Our 197 patients (female sex 86.8%, mean age 52.3 ± 11 years). one following therapies: Rituximab (n=132), Tocilizumab (n=37) or TNF-blockers (n=28). 44.2% have RAMED medical assistance (health insurance scheme for economically underprivileged). Illiteracy noted 45.7% cases. Median one-year per patient €1,665 [€1,472 - €9,879]. There no statistically significant difference between men women (p>0.05), illiterate literate (p>0.05). a other health insurances (p<0.01). Conclusion: This showed that RA had equal access regardless their gender level education. Indeed, system influence biologics. Accessibility those expensive treatments developing country seems be explained by efforts ministry who has allocated substantial budget biologic DMARDs tertiary structures our country. Disclosure Interests: None declared